CHOLESTYRAMINE LIGHT Drug Patent Profile
✉ Email this page to a colleague
When do Cholestyramine Light patents expire, and when can generic versions of Cholestyramine Light launch?
Cholestyramine Light is a drug marketed by Alkem Labs Ltd, Endo Operations, Epic Pharma Llc, Macleods Pharms Ltd, Tagi, Teva, Teva Pharms, and Zydus Pharms. and is included in eight NDAs.
The generic ingredient in CHOLESTYRAMINE LIGHT is cholestyramine. There are eight drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the cholestyramine profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Cholestyramine Light
A generic version of CHOLESTYRAMINE LIGHT was approved as cholestyramine by EPIC PHARMA LLC on August 15th, 1996.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CHOLESTYRAMINE LIGHT?
- What are the global sales for CHOLESTYRAMINE LIGHT?
- What is Average Wholesale Price for CHOLESTYRAMINE LIGHT?
Summary for CHOLESTYRAMINE LIGHT
| US Patents: | 0 |
| Applicants: | 8 |
| NDAs: | 8 |
| Finished Product Suppliers / Packagers: | 10 |
| Clinical Trials: | 39 |
| DailyMed Link: | CHOLESTYRAMINE LIGHT at DailyMed |
Recent Clinical Trials for CHOLESTYRAMINE LIGHT
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Centre Hospitalier Universitaire de Nice | N/A |
| Eli Lilly and Company | Phase 1 |
| Loxo Oncology, Inc. | Phase 1 |
Pharmacology for CHOLESTYRAMINE LIGHT
| Drug Class | Bile Acid Sequestrant |
| Mechanism of Action | Bile-acid Binding Activity |
US Patents and Regulatory Information for CHOLESTYRAMINE LIGHT
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alkem Labs Ltd | CHOLESTYRAMINE LIGHT | cholestyramine | POWDER;ORAL | 211799-001 | Oct 19, 2021 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| Macleods Pharms Ltd | CHOLESTYRAMINE LIGHT | cholestyramine | POWDER;ORAL | 209109-001 | Oct 31, 2024 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| Endo Operations | CHOLESTYRAMINE LIGHT | cholestyramine | POWDER;ORAL | 077203-002 | Aug 26, 2005 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| Teva | CHOLESTYRAMINE LIGHT | cholestyramine | POWDER;ORAL | 074348-002 | May 28, 1998 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| Macleods Pharms Ltd | CHOLESTYRAMINE LIGHT | cholestyramine | POWDER;ORAL | 209109-002 | Oct 31, 2024 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
